China · Delayed Price · Currency is CNY Zhejiang Medicine Statistics
Total Valuation
SHA:600216 has a market cap or net worth of CNY 13.41 billion. The enterprise value is 11.26 billion.
| Market Cap | 13.41B |
| Enterprise Value | 11.26B |
Important Dates
The next estimated earnings date is Tuesday, August 25, 2026.
| Earnings Date | Aug 25, 2026 |
| Ex-Dividend Date | Jul 21, 2025 |
Share Statistics
SHA:600216 has 947.91 million shares outstanding. The number of shares has increased by 0.91% in one year.
| Current Share Class | 947.91M |
| Shares Outstanding | 947.91M |
| Shares Change (YoY) | +0.91% |
| Shares Change (QoQ) | +2.46% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 11.17% |
| Float | 572.35M |
Valuation Ratios
The trailing PE ratio is 18.12 and the forward PE ratio is 11.98.
| PE Ratio | 18.12 |
| Forward PE | 11.98 |
| PS Ratio | 1.52 |
| PB Ratio | 1.18 |
| P/TBV Ratio | 1.26 |
| P/FCF Ratio | 11.11 |
| P/OCF Ratio | 7.98 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.77, with an EV/FCF ratio of 9.32.
| EV / Earnings | 14.98 |
| EV / Sales | 1.28 |
| EV / EBITDA | 7.77 |
| EV / EBIT | 15.19 |
| EV / FCF | 9.32 |
Financial Position
The company has a current ratio of 3.39, with a Debt / Equity ratio of 0.08.
| Current Ratio | 3.39 |
| Quick Ratio | 2.44 |
| Debt / Equity | 0.08 |
| Debt / EBITDA | 0.66 |
| Debt / FCF | 0.79 |
| Interest Coverage | 31.01 |
Financial Efficiency
Return on equity (ROE) is 5.60% and return on invested capital (ROIC) is 6.62%.
| Return on Equity (ROE) | 5.60% |
| Return on Assets (ROA) | 3.29% |
| Return on Invested Capital (ROIC) | 6.62% |
| Return on Capital Employed (ROCE) | 6.14% |
| Weighted Average Cost of Capital (WACC) | 7.09% |
| Revenue Per Employee | 1.63M |
| Profits Per Employee | 138,694 |
| Employee Count | 5,417 |
| Asset Turnover | 0.63 |
| Inventory Turnover | 3.20 |
Taxes
In the past 12 months, SHA:600216 has paid 171.05 million in taxes.
| Income Tax | 171.05M |
| Effective Tax Rate | 21.26% |
Stock Price Statistics
The stock price has increased by +3.66% in the last 52 weeks. The beta is 0.58, so SHA:600216's price volatility has been lower than the market average.
| Beta (5Y) | 0.58 |
| 52-Week Price Change | +3.66% |
| 50-Day Moving Average | 15.50 |
| 200-Day Moving Average | 14.98 |
| Relative Strength Index (RSI) | 38.76 |
| Average Volume (20 Days) | 18,366,028 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHA:600216 had revenue of CNY 8.82 billion and earned 751.31 million in profits. Earnings per share was 0.78.
| Revenue | 8.82B |
| Gross Profit | 2.69B |
| Operating Income | 740.78M |
| Pretax Income | 804.40M |
| Net Income | 751.31M |
| EBITDA | 1.45B |
| EBIT | 740.78M |
| Earnings Per Share (EPS) | 0.78 |
Balance Sheet
The company has 3.24 billion in cash and 957.35 million in debt, with a net cash position of 2.28 billion or 2.41 per share.
| Cash & Cash Equivalents | 3.24B |
| Total Debt | 957.35M |
| Net Cash | 2.28B |
| Net Cash Per Share | 2.41 |
| Equity (Book Value) | 11.37B |
| Book Value Per Share | 11.86 |
| Working Capital | 5.04B |
Cash Flow
In the last 12 months, operating cash flow was 1.68 billion and capital expenditures -473.62 million, giving a free cash flow of 1.21 billion.
| Operating Cash Flow | 1.68B |
| Capital Expenditures | -473.62M |
| Depreciation & Amortization | 706.83M |
| Net Borrowing | 160.31M |
| Free Cash Flow | 1.21B |
| FCF Per Share | 1.27 |
Margins
Gross margin is 30.46%, with operating and profit margins of 8.40% and 8.52%.
| Gross Margin | 30.46% |
| Operating Margin | 8.40% |
| Pretax Margin | 9.12% |
| Profit Margin | 8.52% |
| EBITDA Margin | 16.42% |
| EBIT Margin | 8.40% |
| FCF Margin | 13.69% |
Dividends & Yields
This stock pays an annual dividend of 0.37, which amounts to a dividend yield of 2.65%.
| Dividend Per Share | 0.37 |
| Dividend Yield | 2.65% |
| Dividend Growth (YoY) | 146.67% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 47.37% |
| Buyback Yield | -0.91% |
| Shareholder Yield | 1.06% |
| Earnings Yield | 5.60% |
| FCF Yield | 9.00% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on October 9, 2013. It was a forward split with a ratio of 1.8.
| Last Split Date | Oct 9, 2013 |
| Split Type | Forward |
| Split Ratio | 1.8 |
Scores
SHA:600216 has an Altman Z-Score of 5.06 and a Piotroski F-Score of 5.
| Altman Z-Score | 5.06 |
| Piotroski F-Score | 5 |